The "Agentic AI" Breakthrough
The defining trend of 2026 is the use of Agentic AI to process the massive volumes of raw data generated by digital biomarkers.
Beyond Monitoring: AI no longer just "alerts"; it "reasons." In 2026, Agentic AI tools autonomously clean, de-identify, and tokenize biomarker data for longitudinal studies.
Digital Twins: Biomarker data is used to create "Digital Twins" of patients—predictive models that allow doctors to test a drug’s impact on a virtual version of the patient before the actual prescription is written.
Predictive Diagnostics: Instead of reacting to a "flare," AI identifies subtle "pre-symptomatic" shifts in heart rate variability or activity levels, allowing for "micro-interventions."
1 View
